Highlights from ACR Convergence 2023

View American College of Rheumatology educational opportunities here - https://rheumatology.org/events-programs

 

Spondyloarthropathies
06:48

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: The Burden of Oligoarticular Psoriatic Arthritis in the United States

FEATURING Dafna Gladman
  • 108 views
  • December 26, 2023
16:37

Highlights from ACR Convergence 2023

​​ACR Convergence 2023 Highlights: INVIGORATE-1 - Secukinumab for Treatment of Active axSpA as Discussed by Dr. Atul Deodhar

FEATURING Atul Deodhar
  • 90 views
  • December 11, 2023
  • 1
10:23

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Opioid Prescription Rates in Patients with Ankylosing Spondylitis in the UK Between 2001-2020: An Electronic Health Records (EHR) Analysis

FEATURING Huseyin Berk Degirmenci
  • 65 views
  • December 11, 2023
09:27

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Interpretation of Disease-Specific Questionnaires on Disease Activity, Functional Capacity and Quality of Life in Daily Practice in Axial Spondyloarthritis.

FEATURING Xenofon Baraliakos
  • 113 views
  • December 4, 2023
  • 1
07:30

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: 16- and 52-Week Results from a Randomized, Double-Blind, Phase 3 Study

FEATURING Alan Kivitz
  • 103 views
  • December 4, 2023
16:19

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Spondyloarthritis - Comparing Adult and Pediatric Diseases: Updates and Differences in Management

FEATURING Hemalatha Srinivasalu
  • 296 views
  • November 28, 2023
  • 1
06:14

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: The Use of the ASAS Referral Criteria with Increased Education and Training of Its Use Improves Delays to Diagnosis of Axial Spondyloarthritis

FEATURING Antoni Chan
  • 69 views
  • November 28, 2023
16:43

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: 2023 Classification Criteria for Axial Disease in Youth with Juvenile Spondyloarthritis (axJSpA)

FEATURING Pamela Weiss
  • 76 views
  • November 28, 2023
13:18

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: The Yield of Repeated Assessments in Chronic Back Pain Patients Suspected of Early Axial Spondyloarthritis: Two-year Data from the SPondyloArthritis Caught Early (SPACE) Cohort

FEATURING Mary Lucy Marques
  • 79 views
  • November 28, 2023
10:05

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Results of an Exploratory Analysis from a Phase 3b Study in Patients with Psoriatic Arthritis

FEATURING Maria-Antonietta D'Agostino
  • 123 views
  • November 21, 2023
11:18

Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Clinical Consequences of Infliximab Immunogenicity and the Impact of Proactive Therapeutic Drug Monitoring: Secondary Analyses of a Randomised Clinical Trial

FEATURING Marthe Brun
  • 115 views
  • November 20, 2023
05:25

RheumNow

​​ACR Convergence 2023 Highlights: INVIGORATE-1 Study: IV Secukinumab for Treatment of Active axSpA

FEATURING Atul Deodhar
  • 149 views
  • November 17, 2023
  • 1
07:03

RheumNow

ACR Convergence 2023 Highlights: Correlation Between Patient and Physicians Assessments in PsA

FEATURING Antoni Chan, Avin Maroof
  • 1 view
  • November 22, 2023
08:29

RheumNow

ACR Convergence 2023 Highlights: Using Telemedicine to Improve Diagnosis of AxSpA

FEATURING Antoni Chan, Denis Poddubnyy
  • 2 views
  • November 22, 2023
04:28

RheumNow

ACR Convergence 2023 Highlights: Deep Neural Networks and Radiographic Progression in AxSpA

FEATURING Antoni Chan
  • 3 views
  • November 22, 2023
04:53

RheumNow

ACR Convergence 2023 Highlights: Undiagnosed IBD in AxSpA

FEATURING Eric Dein
  • 14 views
  • November 22, 2023
04:41

RheumNow

ACR Convergence 2023 Highlights: The FOREMOST Study: Apremilast in PsA

FEATURING Peter Nash
  • 131 views
  • November 22, 2023
04:16

RheumNow

ACR Convergence 2023 Highlights: Difficult to Treat axSpA

FEATURING Peter Nash
  • 3 views
  • November 22, 2023
07:04

RheumNow

ACR Convergence 2023 Highlights: Imaging Updates in SpA

FEATURING Rachel Tate, Catherine Blakewell
  • 115 views
  • November 28, 2023
  • 1
08:43

RheumNow

ACR Convergence 2023 Highlights: Teledidactic vs On Campus Training in Musculoskeletal Ultrasound

FEATURING Antoni Chan, Valentin Schäfer
  • 34 views
  • November 28, 2023
05:14

RheumNow

ACR Convergence 2023 Highlights: Treatments in SpA

FEATURING Rachel Tate, Catherine Blakewell
  • 3 views
  • November 28, 2023
04:08

RheumNow

ACR Convergence 2023 Highlights: Bimekizumab in Active AS: 5 Year Study

FEATURING Atul Deodhar
  • 181 views
  • November 28, 2023
04:52

RheumNow

ACR Convergence 2023 Highlights: SpaA Updates: Anti-infliximab Antibodies, Difficult to Treat AxSpa

FEATURING Eric Dein
  • 97 views
  • November 28, 2023
  • 1
48:24

RheumNow

ACR Convergence 2023 Highlights: SpA Topic Panel

FEATURING Sheila Reyes, Rachel Tate, Antoni Chan, Bella Mehta, John J. Cush
  • 142 views
  • November 27, 2023
33:00

RheumNow

ACR Convergence 2023 Highlights: JAK TYK2 Topic Panel

FEATURING John J. Cush, Janet Pope, Michael Putman, David Liew
  • 14 views
  • November 24, 2023
05:29

RheumNow

ACR Convergence 2023 Highlights: Two Studies: TAK-279 (Tyk2) in PsA and Apremilast MRI Study in PsA

FEATURING Guillermo Valenzuela
  • 180 views
  • December 14, 2023
  • 3